Thomas A. Masterson

729 total citations
63 papers, 443 citations indexed

About

Thomas A. Masterson is a scholar working on Psychiatry and Mental health, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Thomas A. Masterson has authored 63 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Psychiatry and Mental health, 24 papers in Endocrinology, Diabetes and Metabolism and 22 papers in Surgery. Recurrent topics in Thomas A. Masterson's work include Sexual function and dysfunction studies (30 papers), Hormonal and reproductive studies (24 papers) and Genital Health and Disease (18 papers). Thomas A. Masterson is often cited by papers focused on Sexual function and dysfunction studies (30 papers), Hormonal and reproductive studies (24 papers) and Genital Health and Disease (18 papers). Thomas A. Masterson collaborates with scholars based in United States, Panama and Canada. Thomas A. Masterson's co-authors include Ranjith Ramasamy, Emad Ibrahim, Manuel Molina, Sirpi Nackeeran, Justin M. Dubin, Himanshu Arora, Jordan C. Best, Russell Saltzman, Rubén Blachman-Braun and Isildinha M. Reis and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and The Journal of Urology.

In The Last Decade

Thomas A. Masterson

58 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas A. Masterson United States 12 176 171 122 85 82 63 443
Tung‐Chin Hsieh United States 14 181 1.0× 181 1.1× 144 1.2× 81 1.0× 97 1.2× 43 494
Nannan Thirumavalavan United States 15 176 1.0× 162 0.9× 160 1.3× 125 1.5× 77 0.9× 83 562
Amarnath Rambhatla United States 10 257 1.5× 150 0.9× 166 1.4× 73 0.9× 135 1.6× 32 564
Pierfrancesco Palego Italy 14 243 1.4× 275 1.6× 156 1.3× 63 0.7× 75 0.9× 20 500
Isabelle Defoy Canada 11 249 1.4× 209 1.2× 109 0.9× 30 0.4× 70 0.9× 17 499
Wanshou Cui China 13 196 1.1× 85 0.5× 82 0.7× 130 1.5× 114 1.4× 30 433
Hisanori Taniguchi Japan 11 85 0.5× 79 0.5× 78 0.6× 99 1.2× 76 0.9× 65 409
Plínio Moreira de Góes Brazil 10 242 1.4× 166 1.0× 194 1.6× 88 1.0× 116 1.4× 14 480
Bülent Semerci Türkiye 10 247 1.4× 105 0.6× 93 0.8× 105 1.2× 113 1.4× 38 507
Uğur Altuğ Türkiye 15 139 0.8× 119 0.7× 68 0.6× 213 2.5× 199 2.4× 40 521

Countries citing papers authored by Thomas A. Masterson

Since Specialization
Citations

This map shows the geographic impact of Thomas A. Masterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Masterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Masterson more than expected).

Fields of papers citing papers by Thomas A. Masterson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas A. Masterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Masterson. The network helps show where Thomas A. Masterson may publish in the future.

Co-authorship network of co-authors of Thomas A. Masterson

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas A. Masterson. A scholar is included among the top collaborators of Thomas A. Masterson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas A. Masterson. Thomas A. Masterson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Best, Jordan C., et al.. (2024). Snip, Support, and Shared Stories: Exploring Reddit Users' Experiences With Vasectomy. Cureus. 16(10). e71374–e71374.
2.
Masterson, Thomas A., et al.. (2023). The adverse effects of commonly used medications on male fertility: a comprehensive review. 4(3). 176–186. 2 indexed citations
3.
Campbell, Katherine, et al.. (2023). Platelet-rich plasma for erectile dysfunction: a review of the current research landscape. Sexual Medicine Reviews. 11(4). 369–374. 3 indexed citations
4.
Nackeeran, Sirpi, et al.. (2023). Risk Factors for Penile Fracture After Intralesional Collagenase Clostridium histolyticum in Peyronie’s Disease. Urology. 183. 117–120. 1 indexed citations
5.
Saltzman, Russell, et al.. (2022). An evaluation of race-based representation among men participating in clinical trials for prostate cancer and erectile dysfunction. Contemporary Clinical Trials Communications. 29. 100986–100986. 9 indexed citations
6.
Nackeeran, Sirpi, et al.. (2022). Diagnosis and treatment patterns of Peyronie’s disease among different racial, ethnic, and regional groups in the Veterans Affairs healthcare system. International Journal of Impotence Research. 35(8). 706–711. 1 indexed citations
7.
Blachman-Braun, Rubén, et al.. (2022). Is tadalafil associated with decreased risk of major adverse cardiac events or venous thromboembolism in men with lower urinary tract symptoms?. World Journal of Urology. 40(7). 1799–1803. 11 indexed citations
8.
Masterson, Thomas A., Manuel Molina, Emad Ibrahim, et al.. (2022). Collagenase Clostridium histolyticum Treatment Improves Degree of Curvature in Peyronie’s Disease with Calcified Plaques. European Urology Focus. 9(1). 55–59. 5 indexed citations
9.
Masterson, Thomas A., et al.. (2022). TRANSGENDER FEMALE PATIENTS WHO UNDERWENT ORCHIECTOMY ARE AT INCREASED RISK OF MAJOR ADVERSE CARDIAC EVENTS (MACE). Fertility and Sterility. 118(4). e21–e21. 1 indexed citations
10.
Firdaus, Fakiha, Manish Kuchakulla, Rehana Qureshi, et al.. (2022). S-nitrosylation of CSF1 receptor increases the efficacy of CSF1R blockage against prostate cancer. Cell Death and Disease. 13(10). 859–859. 8 indexed citations
11.
12.
13.
Masterson, Thomas A., et al.. (2021). Discordant erectile function assessment between validated questionnaire scores and penile Doppler ultrasound in Peyronie’s disease. International Journal of Impotence Research. 34(5). 452–455. 1 indexed citations
14.
15.
Chu, Kevin Y., Shathiyah Kulandavelu, Thomas A. Masterson, et al.. (2020). Short-acting testosterone appears to have lesser effect on male reproductive potential compared with long-acting testosterone in mice. PubMed. 1(1). 46–52. 4 indexed citations
16.
Best, Jordan C., et al.. (2020). A cross-sectional comparison of secondary polycythemia in testosterone-deficient men treated with nasal testosterone gel vs. intramuscular testosterone cypionate. Canadian Urological Association Journal. 15(2). E118–E122. 9 indexed citations
17.
Kuchakulla, Manish, Himanshu Arora, Shathiyah Kulandavelu, et al.. (2019). Age Induced Nitroso-Redox Imbalance Leads to Subclinical Hypogonadism in Male Mice. Frontiers in Endocrinology. 10. 190–190. 4 indexed citations
18.
Masterson, Thomas A., et al.. (2019). Variation in collagenase Clostridium histolyticum practice patterns: a Survey of ISSM Members. International Journal of Impotence Research. 31(6). 439–443. 2 indexed citations
19.
Masterson, Thomas A., et al.. (2018). Time to improvement in semen parameters after microsurgical varicocelectomy in men with severe oligospermia. Canadian Urological Association Journal. 13(3). E66–E69. 18 indexed citations
20.
Clavijo, Raul I., et al.. (2017). Three-piece Penile Prosthesis Implantation in Refractory Ischemic Priapism—Tips and Tricks. Urology. 106. 233–235. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tung‐Chin Hsieh Breakdown of academic impact, for papers by Nannan Thirumavalavan Breakdown of academic impact, for papers by Amarnath Rambhatla Breakdown of academic impact, for papers by Pierfrancesco Palego Breakdown of academic impact, for papers by Isabelle Defoy Breakdown of academic impact, for papers by Wanshou Cui Breakdown of academic impact, for papers by Hisanori Taniguchi Breakdown of academic impact, for papers by Plínio Moreira de Góes Breakdown of academic impact, for papers by Bülent Semerci Breakdown of academic impact, for papers by Uğur Altuğ
Rankless by CCL
2026